Clear guidance on prescription weight-loss treatment
Counterfeit and illegally supplied GLP-1 pens are a growing concern in the UK. This guide explains what legitimate packaging and pharmacy paperwork should look like, why unusually cheap online offers warrant caution, and how to report a suspect product to the MHRA.
Moving to a new weight-loss clinic partway through GLP-1 treatment is a reasonable decision, but it is rarely a simple one. Dose history, cold-chain records and repeat-prescription timing all have to travel with you, and the administrative gap between providers is where treatments quietly stall.
A home-delivered GLP-1 pen can look fine and still have had a difficult journey. This guide sets out a calm, practical routine for checking the parcel, reading temperature indicators, photographing evidence and speaking to an online pharmacy when the cold chain looks doubtful.
A used GLP-1 pen is not ordinary household waste. This guide explains how patients in the UK can store, transport and return sharps safely, including options for shared homes and private prescriptions in 2026.
Many UK patients on GLP-1 treatment describe a quieter relationship with alcohol — fewer pints, untouched wine, an easier refusal at the pub. This article examines what that change means, where safety questions arise, and why an honest word with your prescriber is part of good treatment rather than a confession.
Private weight-loss clinics can pause prescriptions, change ownership or disappear with little notice. This guide explains how UK patients can secure their records, avoid an unmanaged gap in treatment and transfer to a new prescriber without guesswork.
Starting a GLP-1 medicine is only the opening chapter. Around six months in, an NHS clinic will reassess whether the treatment is earning its place in your care plan, and that decision rests on more than one weigh-in. This guide explains what reviewers examine, how to assemble your evidence, and what happens when progress has been slower than hoped.
For many British women, the late 40s and 50s bring both the greatest struggle with weight and the greatest hormonal turbulence. This guide examines how perimenopause and menopause interact with GLP-1 medication, and what questions to raise with a prescriber before starting.
A suppressed appetite changes more than your waistline — it reshapes how your household buys, cooks and throws away food. This practical guide helps UK patients plan their kitchen, shopping and batch-cooking habits for life on GLP-1 treatment.
Starting GLP-1 treatment often leaves Britain's kitchens stocked for an appetite that no longer exists. This practical guide walks through a room-by-room audit, from the overflowing freezer to the bulk-bought snack cupboard, and explains how to restock for smaller, protein-first portions without waste or guilt.
Prescription weight-loss medication doesn't just change appetites — it quietly rearranges the rituals built around them, from Sunday roasts to birthday cake. This reflective piece explores what patients lose, what they keep, and how to decline a second helping without declining the moment itself.
Men account for the majority of obesity-related hospital admissions in England, yet they form a small fraction of patients receiving GLP-1 prescriptions. We examine the cultural, clinical and commercial reasons behind the gap — and what finally prompts men to ask for help.
A GLP-1 prescription doesn't just change the patient — it reshapes the family kitchen. We look at how UK households are adapting mealtimes when one person has lost their appetite and everyone else still needs feeding, with practical strategies from a registered dietitian.
Rapid weight loss on GLP-1 medication does not distinguish between fat and muscle, and losing lean tissue quietly undermines metabolism, strength and long-term health. This guide explains why muscle matters, how to defend it through protein and resistance training, and the warning signs worth raising with your prescriber.
Taking your weight-loss medication on holiday requires more planning than packing a suitcase. This guide covers refrigeration, customs paperwork, time-zone scheduling and what to do if a pen goes missing mid-trip.
Vivid dreams, restless nights and mid-afternoon energy dips are among the least discussed effects reported by British patients starting GLP-1 medicines. We examine what the evidence says, when fatigue warrants a call to your prescriber, and how to time injections, meals and exercise for a better night's rest.
As GLP-1 prescriptions rise across Britain, more employees are managing weekly injections, side effects and appetite changes around shifts, meetings and commutes. This feature looks at disclosure, workplace stigma and the practical steps that keep treatment safe during working hours.
Weight loss is the headline, but GLP-1 receptor agonists interact with organs throughout the body. We review the documented benefits, the recognised risks and the MHRA warnings every UK patient should understand before starting treatment.
Patients tell us they can discuss dosage with a pharmacist more easily than with their own families. This opinion piece examines the stigma surrounding GLP-1 medication in Britain — and why silence can carry its own risks.
Millions of UK workers hold private medical insurance or workplace health schemes without realising what they cover. This guide explains how to interrogate your policy documents, approach your employer, and make the case for funding prescription weight-loss treatment.